Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2018.09.006
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2018
Authors
Publisher
Elsevier BV